EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudie

Comparison of the Risk of Paradoxical Psoriasis between Monoclonal Antibody and Non-monoclonal Antibody Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis: An Observational Study Using a Claims Database

Minoru Shimazaki, Yutaka Matsuyama, Daisuke Koide

Biological and Pharmaceutical Bulletin · 2025

DOI: 10.1248/bpb.b25-00058 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Minoru Shimazaki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Integrated Health Sciences, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo…. Hauptthemen laut MEDLINE: Psoriasis, Arthritis, Rheumatoid, Tumor Necrosis Factor-alpha, Antirheumatic Agents. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisArthritis, RheumatoidTumor Necrosis Factor-alphaAntirheumatic AgentsAntibodies, MonoclonalHumansFemaleMaleMiddle AgedEtanerceptDatabases, FactualAdultCertolizumab PegolAgedAdalimumab

Stichwörter der Autor:innen

monoclonal antibodyparadoxical psoriasisrheumatoid arthritistumor necrosis factor-α inhibitor

Substanzen

Tumor Necrosis Factor-alphaEtanerceptAntirheumatic AgentsCertolizumab PegolAdalimumabAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, School of Integrated Health Sciences, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Department of Biostatistics, School of Public Health, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Zitieren

APA

Shimazaki, M., Matsuyama, Y., & Koide, D. (2025). Comparison of the Risk of Paradoxical Psoriasis between Monoclonal Antibody and Non-monoclonal Antibody Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis: An Observational Study Using a Claims Database. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00058

Vancouver

Shimazaki M, Matsuyama Y, Koide D. Comparison of the Risk of Paradoxical Psoriasis between Monoclonal Antibody and Non-monoclonal Antibody Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis: An Observational Study Using a Claims Database. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b25-00058

BibTeX
@article{Shimazaki2025,
  author = {Shimazaki, Minoru and Matsuyama, Yutaka and Koide, Daisuke},
  title = {Comparison of the Risk of Paradoxical Psoriasis between Monoclonal Antibody and Non-monoclonal Antibody Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis: An Observational Study Using a Claims Database},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/bpb.b25-00058}
}
Kostenlos starten →